| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.8 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.8 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.8 |